SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-292209
Filing Date
2020-11-13
Accepted
2020-11-13 06:31:17
Documents
64
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d943701d10q.htm 10-Q 375085
2 EX-31.1 d943701dex311.htm EX-31.1 10561
3 EX-31.2 d943701dex312.htm EX-31.2 10661
4 EX-32.1 d943701dex321.htm EX-32.1 3193
5 EX-32.2 d943701dex322.htm EX-32.2 3021
  Complete submission text file 0001193125-20-292209.txt   3054312

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bntc-20200930.xml EX-101.INS 628148
7 XBRL TAXONOMY EXTENSION SCHEMA bntc-20200930.xsd EX-101.SCH 33648
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bntc-20200930_cal.xml EX-101.CAL 34409
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bntc-20200930_def.xml EX-101.DEF 99984
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20200930_lab.xml EX-101.LAB 263952
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20200930_pre.xml EX-101.PRE 202703
Mailing Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000
Business Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000 61(0)3 8692-7222
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39267 | Film No.: 201309103
SIC: 2834 Pharmaceutical Preparations